Cancer Therapy
Orlistat is inhibitor of fatty acid synthase with antitumor activity
Published in Medical Letter on the CDC and FDA, May 16th, 2004
According to published research from the United States, "One of the fundamental principles of pharmacology is that most drugs have side effects. Although considerable attention is paid to detrimental side effects, drugs can also have beneficial side effects. Given the time and expense of drug development, it would be particularly exciting if a systematic method could be applied to reveal all of the activities, including the unappreciated actions, of a potential drug.
"The present study takes the first step along this path," said Steven J. Kridel and collaborators at the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Drug Resistance
Daptomycin useful for treating drug-resistant Gram-positive pathogens - Parasitology
Common intestinal parasites reviewed - Vaccine Safety
Vaccine Adverse Event Reporting System database reviewed - Wuchereria
Wuchereria bancrofti infection more prevalent in Haiti lowlands - AIDS/HIV Therapy
Crack cocaine use reduces antiviral therapy use in women with HIV - AIDS/HIV Vaccine
Vaccine allows for infection control in macaques exposed to SHIV - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
